TAZESTIG Trademark

Trademark Overview

On Tuesday, January 28, 2014, a trademark application was filed for TAZESTIG with the United States Patent and Trademark Office. The USPTO has given the TAZESTIG trademark a serial number of 86177427. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, December 15, 2023. This trademark is owned by Glaxo Group Limited. The TAZESTIG trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
tazestig

General Information

Serial Number86177427
Word MarkTAZESTIG
Filing DateTuesday, January 28, 2014
Status710 - CANCELLED - SECTION 8
Status DateFriday, December 15, 2023
Registration Number5211494
Registration DateTuesday, May 30, 2017
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 30, 2014

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
Translation of Words in MarkThe wording "TAZESTIG" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, December 15, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS

Trademark Events

Event DateEvent Description
Friday, December 15, 2023CANCELLED SEC. 8 (6-YR)
Wednesday, November 9, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, November 9, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, November 9, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, November 9, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, November 9, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, May 30, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, December 9, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, December 9, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, May 30, 2017REGISTERED-PRINCIPAL REGISTER
Tuesday, April 25, 20171(B) BASIS DELETED; PROCEED TO REGISTRATION
Thursday, February 23, 2017NOTICE OF ALLOWANCE CANCELLED
Thursday, February 23, 2017TEAS DELETE 1(B) BASIS RECEIVED
Tuesday, August 9, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 8, 2016SOU EXTENSION 3 GRANTED
Thursday, July 28, 2016SOU EXTENSION 3 FILED
Thursday, July 28, 2016SOU TEAS EXTENSION RECEIVED
Saturday, March 19, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 18, 2016SOU EXTENSION 2 GRANTED
Thursday, February 11, 2016SOU EXTENSION 2 FILED
Monday, March 14, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, February 11, 2016SOU TEAS EXTENSION RECEIVED
Thursday, July 2, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 30, 2015SOU EXTENSION 1 GRANTED
Tuesday, June 30, 2015SOU EXTENSION 1 FILED
Tuesday, June 30, 2015SOU TEAS EXTENSION RECEIVED
Tuesday, June 23, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, February 24, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 30, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 30, 2014PUBLISHED FOR OPPOSITION
Wednesday, December 10, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, November 22, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Saturday, November 22, 2014ASSIGNED TO LIE
Tuesday, November 4, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, November 4, 2014EXAMINER'S AMENDMENT ENTERED
Tuesday, November 4, 2014NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, November 4, 2014EXAMINERS AMENDMENT E-MAILED
Tuesday, November 4, 2014EXAMINERS AMENDMENT -WRITTEN
Monday, November 3, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, November 3, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, November 3, 2014TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Friday, May 2, 2014NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, May 2, 2014LETTER OF SUSPENSION E-MAILED
Friday, May 2, 2014SUSPENSION LETTER WRITTEN
Friday, May 2, 2014ASSIGNED TO EXAMINER
Friday, February 7, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, January 31, 2014NEW APPLICATION ENTERED

Related Keywords

tazestig pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological